Working… Menu
Trial record 1 of 7 for:    crovalimab
Previous Study | Return to List | Next Study

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS) (COMMUTE-p)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04958265
Recruitment Status : Not yet recruiting
First Posted : July 12, 2021
Last Update Posted : September 5, 2021
Chugai Pharmaceutical
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 12, 2025
Estimated Study Completion Date : March 16, 2029